ABL Bio (Korea) Top Management
ABL Bio employs about 7 people. The company is managed by 7 executives with a total tenure of roughly 17 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of ABL Bio's management performance can provide insight into the company performance.
| Jung Kim Insider MD COO |
| Jaecheon Lee Insider MD CFO |
ABL |
ABL Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.3051) % which means that it has lost $0.3051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 5.5983 %, meaning that it generated $5.5983 on every $100 dollars invested by stockholders. ABL Bio's management efficiency ratios could be used to measure how well ABL Bio manages its routine affairs as well as how well it operates its assets and liabilities.ABL Bio Workforce Comparison
ABL Bio is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 130. ABL Bio holds roughly 7.0 in number of employees claiming about 5% of stocks in Biotechnology industry.
ABL Bio Notable Stakeholders
An ABL Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ABL Bio often face trade-offs trying to please all of them. ABL Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ABL Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jung Kim | MD COO | Profile | |
| Jaecheon Lee | MD CFO | Profile | |
| Jae Jung | MD Discovery | Profile | |
| Jong Kim | MD Devel | Profile | |
| Sang Lee | Founder CEO | Profile | |
| You WeonKyoo | Head MD | Profile | |
| Jong Won | Head Devel | Profile |
ABL Bio Workforce Analysis
Traditionally, organizations such as ABL Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ABL Bio within its industry.ABL Bio Manpower Efficiency
Return on ABL Bio Manpower
| Revenue Per Employee | 761.7M | |
| Revenue Per Executive | 761.7M | |
| Net Loss Per Employee | 6.2B | |
| Net Loss Per Executive | 6.2B |
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |